QA: Kronos Bio Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001741830_2024_Kronos_Bio_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001741830, Kronos Bio Inc

  xvar xval
0 AssetsCurrent 178,778,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 10,252,000
3 remainder_Assets 24,249,000
4 LiabilitiesCurrent 24,695,000
5 LiabilitiesNoncurrent 29,506,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 39,668,915
9 ResearchAndDevelopmentExpense 83,854,448
10 remainder_Expenses 0
11 remainder_Revenues 6,288,000
12 remainder_NetIncome 7,562,460
13 remainder_ComprehensiveNetIncome -751,477
  yvar yval
0 Assets 213,279,000
1 Liabilities 54,201,000
2 Expenses 123,523,363
3 Revenues 6,288,000
4 StockholdersEquity 159,078,000
5 NetIncome -109,672,903
6 ComprehensiveNetIncome -110,048,642
7 BaseVar 202,802,650
8 EconomicCapitalRatiobeforeLimitedLiability 1.77
9 EconomicCapitalRatio 2.87

Edgar->Model Mapping

Feature Distribution

Change over Time